Healthway Medical Corporation Ltd
SGX:5NG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Healthway Medical Corporation Ltd
Healthway Medical Corporation Ltd
Cost of Revenue
Healthway Medical Corporation Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Healthway Medical Corporation Ltd
SGX:5NG
|
Cost of Revenue
-S$26.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
Cordlife Group Ltd
SGX:P8A
|
Cost of Revenue
-S$17.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-2%
|
|
|
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
Cost of Revenue
-S$21.3m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-11%
|
|
|
T
|
Talkmed Group Ltd
SGX:5G3
|
Cost of Revenue
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
HC Surgical Specialists Ltd
SGX:1B1
|
Cost of Revenue
-S$2.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
EUDA Health Holdings Ltd
NASDAQ:EUDA
|
Cost of Revenue
-$2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Healthway Medical Corporation Ltd
Glance View
Healthway Medical Corp. Ltd. operates as an investment holding company. The principal activities of the Company are those of an investment holding company and to carry on the business of healthcare management. The company offers medical services including general practitioner and family medicine clinics, health screening, adult specialists, and allied healthcare services. Its segments include Primary Healthcare and Specialist Healthcare. Its Primary Healthcare segment consists of family medicine, dentistry, healthcare benefit management and investment in strategic medical-related business. Its Specialist Healthcare segment consists of pediatrics, orthopedics, aesthetic medicine, obstetrics and gynecology, and Nobel specialists consisting of cardiology, gastroenterology, psychiatry, ophthalmology (eye), otorhinolaryngology (ear, nose and throat) and general surgery. Its subsidiaries include Healthway Medical Group Pte Ltd, Unimedic Pte. Ltd., and China Healthway Pte. Ltd.
See Also
What is Healthway Medical Corporation Ltd's Cost of Revenue?
Cost of Revenue
-26.9m
SGD
Based on the financial report for Jun 30, 2023, Healthway Medical Corporation Ltd's Cost of Revenue amounts to -26.9m SGD.
What is Healthway Medical Corporation Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%
Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Healthway Medical Corporation Ltd have been -10% over the past three years , -4% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
